TFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA); First clinical study in healthy subjects of a direct-to-lung, Thin Film Freezing (TFF) dry-powder formul

Press/Media: Press / Media

PeriodNov 24 2019 → Nov 27 2019

Media coverage

19

Media coverage

  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletBioSpace
    CountryUnited States
    Date11/27/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA); First clinical study in healthy subjects of a direct-to-lung, Thin Film Freezing (TFF) dry-powder formul
    Media name/outletBusiness Wire
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA); First clinical study in healthy subjects of a direct-to-lung, Thin Film Freezing (TFF) dry-powder formul
    Media name/outletBusiness Wire
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletIndia Pharma News
    CountryIndia
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF PHARMACEUTICALS : Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletMarketScreener.com
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletWallstreet Online
    CountryGermany
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletDigital Media Net
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletCrwe World
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletJotup
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletCIT
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletHerald Chronicle
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletManchester Times
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletTullahoma News
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletElk Valley Times
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Inc: TFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA) (Businesswire)
    Media name/outletAvanza Bank AB
    CountrySweden
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletFOX21 Delmarva
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletErie News Now
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletTulsa CW
    CountryUnited States
    Date11/25/19
    PersonsJay I Peters
  • TitleTFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA)
    Media name/outletAcrofan
    Date11/24/19
    PersonsJay I Peters